We have extended these studies to utilize a bioinformatic-driven approach to characterize the impact of TGFB2 mRNA, in combination with potential prognostic markers, on OS in ovarian cancer patients from The Cancer Genome Atlas (TCGA) database. This evidence concerns the gene TGFB2 and ovarian cancer.